Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 31-40 of 515 for

  • Results filtered:
  • Study status: Open/Status Unknown
Edit search filters
  1. Infection Outcomes Assessment of Absorbable Antibacterial Soft Tissue Support in Breast Reconstruction

    Rochester, MN

  2. Oligomets pancreas SBRT

    Jacksonville, FL

  3. Study of ORIC-114 in Patients With Advanced Solid Tumors Harboring an EGFR or HER2 Alteration

    Jacksonville, FL, Rochester, MN

  4. A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors

    Scottsdale/Phoenix, AZ, Rochester, MN

  5. First in Human Study of TORL-4-500 in Participants With Advanced Cancer

    Scottsdale/Phoenix, AZ

  6. YH001 Plus Envafolimab With or Without Doxorubicin in Patients With Advanced or Metastatic Sarcoma

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  7. SENTI-202: Off-the-shelf Logic Gated CAR NK Cell Therapy in Adults With CD33 and/or FLT3 Blood Cancers Including AML/MDS

    Jacksonville, FL

  8. Safety of MT-401-OTS in Patients with Relapsed AML or MDS

    Jacksonville, FL

  9. A Study Of Radiation Dosimetry, Safety, And Tolerability Of Extended Lutetium (177Lu) Vipivotide Tetraxetan Treatment In Chemo-naïve Adults With Metastatic Castration-resistant Prostate Cancer: RADIOpharmaceutical DOSimetry Evaluation (RADIODOSE) Study

    Rochester, MN

  10. Dose Escalation Study of mRNA-2752 for Intratumoral Injection to Participants in Advanced Malignancies

    Scottsdale/Phoenix, AZ

.

Mayo Clinic Footer